| Authors: |
Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Lazarus E; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Stieh DJ; Janssen Vaccines & Prevention, Leiden, The Netherlands., Yates N; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Zhang L; Duke University, Durham, North Carolina, United States of America., Sawant S; Duke University, Durham, North Carolina, United States of America., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Morris D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Randhawa A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Hendriks J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Wegmann F; Janssen Vaccines & Prevention, Leiden, The Netherlands., Gill KM; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Gray GE; South African Medical Research Council, Cape Town, South Africa., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Martin T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America., Tomaras G; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. |
